Pharmacists in Middleboro, Massachusetts


13 Pharmacists found in Middleboro
female pharmacist

Caryn Stokes


Pharmacist
8 Merchants Way, Middleboro, MA 02346
508-923-2989    

male pharmacist

Mr. David Wayne Bolivar, RPH


Pharmacist
8 Merchants Way, Middleboro, MA 02346
508-923-2989    

female pharmacist

Deborah Ann Howie, R.PH.



131 S Main St, Middleboro, MA 02346
508-949-0149     508-946-4682



male pharmacist

Duan Le


Pharmacist
131 S Main St, Middleboro, MA 02346
508-946-0149    

female pharmacist

Kerianne Mcsolla, PHARMD, RPH


Pharmacist
131-133 Main St, Middleboro, MA 02346
508-946-1049    

female pharmacist

Kerry Hardiman


Pharmacist
438 W Grove St, Middleboro, MA 02346
508-946-0080    

female pharmacist

Lauren M Harding


Pharmacist - Geriatric
23 Holly Tree Ln, Middleboro, MA 02346
781-217-0254     508-923-0241

female pharmacist

Dr. Lyndsey Barbehenn, PHARMD


Pharmacist
438 W Grove St Ste B, Middleboro, MA 02346
508-946-0080     508-947-8967

male pharmacist

Marc N Racicot


Pharmacist
8 Merchants Way, Middleboro, MA 02346
508-923-2989    

male pharmacist

Dr. Michael Ryan Correia, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
131-133 Main St, Middleboro, MA 02346
508-946-0149     508-946-4682

female pharmacist

Ranin Kassab, PHARMD


Pharmacist
438 W Grove St, Middleboro, MA 02346
508-946-0080    

male pharmacist

Ronald Alan Cohen, R.PH.


Pharmacist
131 S Main St, Middleboro, MA 02346
508-946-0149     508-946-4682

female pharmacist

Shayna Baker


Pharmacist
131 S Main St, Middleboro, MA 02346
508-946-0149    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.